Laser In Situ Fenestration Study
A legfontosabb adatok
- Ki végzi
- Jonathan Bath
- Hol
- Columbia (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 15 fő, tervezett
- Kezdés
- 2024. okt. 15.
- Várható befejezés
- 2033. jún.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Fenestrated Endovascular Aneurysm Repair using the LIFE Device System
- A regiszteradat frissítve
- 2026. szeptember 17.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a large aortic aneurysm (a swelling of the body's main blood vessel) near the kidney arteries. It tests a new laser device, the LIFE device, for repair from inside the vessel.
- Életkor
- 18 years or older
- Nem
- Men and women
- A betegség stádiuma
- Aortic aneurysm in the juxtarenal or pararenal aorta, over 5.5 cm (2,2 in) in men or over 5.0 cm (2 in) in women, or growing fast with a high risk of bursting. The repair must cover the kidney and gut artery branches. The vessel shape and sizes must fit the device.
- Korábbi kezelés
- People cannot have open surgery, or open surgery carries high risk for them. Currently approved endovascular options are not possible for them. They are not willing or able to travel to sites with manufacturer-made trial devices.
A részvétel fő kizáró okai
- Allergy to device materials, such as Nitinol, polyester, Platinum-Iridium, stainless steel, fluoropolymer or heparin
- Allergy or problem with blood thinners or contrast dye that cannot be managed
- A bleeding or clotting disorder that cannot be corrected
- Body size that blocks X-ray imaging of the aorta or is too large for the equipment
- Taking part in another study of an experimental therapy
A regiszter feltételei, szó szerint
Mind a 19 feltétel megnézéseKevesebb
Ki vehet részt
- Aortic aneurysm >5.5 cm in a man or > 5.0 cm in a woman or rapid expansion deemed at significant risk for rupture in the juxtarenal or pararenal aorta
- Endovascular aortic repair requiring coverage of renovisceral branches
- Not candidate or at high risk for open repair. For example, but not exclusively, due to renal dysfunction, previous abdominal surgery, obese body habitus, previous coronary bypass grafts or high cardiac risk, chronic obstructive pulmonary disease (COPD) or on oxygen at rest, poorly controlled diabetes, current smoking, or antiplatelet or anticoagulation use
- Proximal aortic landing zone in Zone 5 of the aorta or previous graft of at least 10 mm in length and diameter of between 20 and 40 mm
- Distance ≥ 5 mm between top of graft fabric and renovisceral branch orifice
- At least a 5 mm iliofemoral artery to accept the endovascular stent graft device and an axillary brachial artery of sufficient diameter to accept the laser catheter
- Renovisceral diameter between 4 and 13 mm at the origin
- At the time of case planning, the patient's anatomy appears amenable to complete exclusion of the aneurysm with laser fenestration techniques
- Not willing or able to travel to sites that have access to manufacturer-made investigational endovascular devices
- Not a candidate for currently approved endovascular options
- 18 years or older
- Patient or legally authorized representative agrees to participate in the study and provides written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
- Patient is able and willing to meet all study requirements, including participating in follow up evaluations and attending required assessment visits
Ki nem vehet részt
- Concurrent participation in another research protocol for investigation of an experimental therapy
- Known sensitivities or allergies to the materials of construction of the devices, including Nitinol, polyester, Platinum-Iridium, stainless steel, fluoropolymer, and heparin
- Known hypersensitivity or contraindication to anticoagulation or contrast media that cannot be adequately medically managed
- Uncorrectable coagulopathy
- Body habitus that would inhibit radiographic visualization of the aorta or exceeds the safe capacity of equipment
- Subject has been judged to be unsuitable for participation in the study by the Investigator for any reason
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- University of Missouri - ColumbiaColumbia, Egyesült ÁllamokContact: Jonathan Bath, MDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to learn about a new device, named the LIFE device, to treat people with aneurysms (swellings) in the aorta (large, main blood vessel that delivers blood from the heart to the body). The main questions this trial aims to answer are:
A teljes eredeti leírásKevesebb
* If the LIFE device works to treat aortic aneurysms * What medical problems participants have when the LIFE device is used Participants will undergo treatment with the LIFE device and thereafter at 30 days, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years have their pulses checked, bloodwork to check kidney function (BUN and serum creatinine), and a CT scan of the aneurysm area.
A vizsgálat csoportja
- Endovascular Aneurysm RepairA vizsgált kezelés
Fenestrated Endovascular Aneurysm Repair using the LIFE Device System
Kezelés: Fenestrated Endovascular Aneurysm Repair using the LIFE Device System
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Laser In Situ Fenestration for Endovascular Aortic Repair (LIFE) Study
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. szeptember 17.